Evidence map›Paper›PMID 19916789›Full record

ArticleMicrobial drug resistance (Larchmont, N.Y.)2010

Development of a DNA microarray to detect antimicrobial resistance genes identified in the National Center for Biotechnology Information database.

Jonathan G Frye, Rebecca L Lindsey, Gaelle Rondeau, Steffen Porwollik, Fred Long, Michael McClelland, Charlene R Jackson, Mark D Englen, Richard J Meinersmann, Mark E Berrang and 5 more

Open access · greenAbstract read
In one paragraph

Article in Microbial drug resistance (Larchmont, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jonathan G FryeBacterial Epidemiology and Antimicrobial Resistance Research Unit, Richard B. Russell Research Center, Agriculture Research Service, U.S. Department of Agriculture, 950 College Station Road, Athens, GA 30605, USA. jonathan.frye@ars.usda.gov
Rebecca L Lindsey
Gaelle Rondeau
Steffen Porwollik
Fred Long
Michael McClelland
Charlene R Jackson
Mark D Englen
Richard J Meinersmann
Mark E Berrang
Johnnie A Davis
John B Barrett
Jennifer B Turpin
Sutawee N Thitaram
Paula J Fedorka-Cray
Sidney Kimmel Cancer Center · US

Funding

DETAILED RESTRICTION MAP--SALMONELLA TYPHIMURIUM GENOMER01AI034829 · NIAID · SIDNEY KIMMEL CANCER CENTER · PI MCCLELLAND, MICHAEL · 1993 to 2006
$1.9M
Salmonella Gene Expression in Complex EnvironmentsR21AI057733 · NIAID · SIDNEY KIMMEL CANCER CENTER · PI MCCLELLAND, MICHAEL · 2004 to 2004
$345k
NIAID NIH HHS R01AI34829NIAID NIH HHS R21AI057733
6 · The paper itself

Abstract

To understand the mechanisms and epidemiology of antimicrobial resistance (AR), the genetic elements responsible must be identified. Due to the myriad of possible genes, a high-density genotyping technique is needed for initial screening. To achieve this, AR genes in the National Center for Biotechnology Information GenBank database were identified by their annotations and compiled into a nonredundant list of 775 genes. A DNA microarray was constructed of 70mer oligonucelotide probes designed to detect these genes encoding resistances to aminoglycosides, beta-lactams, chloramphenicols, glycopeptides, heavy metals, lincosamides, macrolides, metronidazoles, polyketides, quaternary ammonium compounds, streptogramins, sulfonamides, tetracyclines, and trimethoprims as well as resistance transfer genes. The microarray was validated with two fully sequenced control strains of Salmonella enterica: Typhimurium LT2 (sensitive) and Typhi CT18 (multidrug resistance [MDR]). All resistance genes encoded on the MDR plasmid, pHCM1, harbored by CT18 were detected in that strain, whereas no resistance genes were detected in LT2. The microarray was also tested with a variety of bacteria, including MDR Salmonella enterica serovars, Escherichia coli, Campylobacter spp., Enterococcus spp., methicillin-resistant Staphylococcus aureus, Listeria spp., and Clostridium difficile. The results presented here demonstrate that a microarray can be designed to detect virtually all AR genes found in the National Center for Biotechnology Information database, thus reducing the subsequent assays necessary to identify specific resistance gene alleles.

Indexed as

Databases, Nucleic AcidGenes, BacterialCampylobacterClostridioides difficileDNA, BacterialDrug Resistance, Multiple, BacterialEnterococcusEscherichia coliGlassHumansListeriaMethicillin-Resistant Staphylococcus aureusOligonucleotide Array Sequence AnalysisPlasmidsSalmonella entericaSensitivity and SpecificityDNA, Bacterial

Identifiers

PMID19916789
PMCPMC3116450
OpenAlexW2082527969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.